Latest Integra Lifesciences Holdings Corp (IART) Headlines
Integra LifeSciences to Participate in the Barclays Global Healthcare Conference in March
GlobeNewswire - Mon Mar 03, 3:15PM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conference next month:
Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges
GlobeNewswire - Thu Feb 27, 8:51AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the Integra Titanium Bone Wedges, designed for internal fixation for bone fractures or osteotomies in the foot and ankle. The system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), and will be featured at the American College of Foot and Ankle Surgeons (ACFAS) 72 Annual Scientific Conference, February 27 - March 2, 2014, in Orlando, Florida.
Integra LifeSciences Appoints Kenneth Burhop, Ph.D., as Corporate Vice President and Chief Scientific Officer
GlobeNewswire - Tue Feb 25, 7:00AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Kenneth Burhop has joined Integra as Corporate Vice President, Chief Scientific Officer. Dr. Burhop will be responsible for setting Integra's strategic scientific vision and roadmap, and will lead the Company's portfolio prioritization and management, and the scientific evaluation of corporate development and new product opportunities.
Integra LifeSciences Reports Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Feb 25, 5:00AM CST
Increases Fourth Quarter Revenues 3% to $221 Million
Integra LifeSciences to Participate in the 2014 Citi Global and RBC Capital Markets Healthcare Conferences in February
GlobeNewswire - Mon Feb 10, 8:00AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month:
Global Biomaterials Market 2012-2016: High R&D Costs Could Pose a Challenge to the Growth of the Market
M2 - Wed Feb 05, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/kl58bq/global) has announced the addition of the "Global Biomaterials Market 2012-2016" report to their offering. The analysts forecast the Global Biomaterials market to grow at a CAGR of 14.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biomaterials market has also been witnessing the emergence of innovative biomaterial products. However, high R&D costs could pose a challenge to the growth of this market. The key vendors dominating this space include Biomet Inc., Evonik Industries AG, Exactech Inc., and Wright Medical Group Inc. The other vendors mentioned in this report are 3DM Inc., AdvanSource Biomaterials Corp., Allergan Inc., Alphatec Spine Inc., Amedica Corp., Angiotech Pharmaceuticals Inc., Basf SE, Bayer AG, Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioSyntech Inc., Cam Bioceramics BV, Carpenter Technology Corp., Ceradyne Inc., Ceramtec Collagen Matrix Inc., CollPlant Holdings Ltd., Covalon Technologies Ltd., CryoLife Inc., Dentsply International Inc., Depuy Orthopaedics Inc., Dsm Biomedical Inc., ETEX Corp., Heraeus Medical Components Inc., Hycail Finland OY, Integra LifeSciences Holdings Corp., Invibio Ltd., Kyocera Corp., Landec Corp., Materion Corp., Medtronic Inc., Morgan Technical Ceramics, Orthovita Inc., Osteotech Inc., Purac Biomaterials, RTI Biologics Inc., Sigma-Aldrich Corp., Starch Medical Inc., Stryker Corp., Ticona GmbH, Ulbrich Stainless Steels & Special Metals Inc., and Zimmer Holdings Inc. Commenting on the report, an analyst from the team said: There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation. For more information visit http://www.researchandmarkets.com/research/kl58bq/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Use Options For A Chance To Buy IART At A 24% Discount
at The Street - Tue Feb 04, 11:29AM CST
Looking back to 90 days ago, Integra LifeSciences Holdings Corp priced a 3,500,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go...
Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien
GlobeNewswire - Wed Jan 15, 3:05PM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of DuraSeal product lines from Covidien. Now, together with our DuraGen(R) family of grafts, Integra offers surgeons the largest portfolio of dural repair solutions.
Integra LifeSciences to Host Its Fourth Quarter 2013 Earnings Results Conference Call on February 25, 2014
GlobeNewswire - Mon Jan 13, 8:03AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2013 financial results on Tuesday, February 25, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
Annual J.P. Morgan Healthcare Conference Presentations, Results of Self-Tender Offer, and Executive Appointment - Research Report on ICU Medical, Integra, Taro, AMAG, and Array BioPharma
PR Newswire - Fri Jan 10, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting ICU Medical, Inc. (NASDAQ: ICUI), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Taro Pharmaceutical Industries Ltd. (NYSE: TARO), AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), and Array BioPharma Inc. (NASDAQ: ARRY). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Integra Lifesciences Holdings Corp (IART) Enters Overbought Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 7:38AM CST
Integra Lifesciences Holdings Corp (IART) Enters Overbought Territory
Integra LifeSciences to Participate in the 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 30, 3:05PM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Peter Arduini, Integra's President and Chief Executive Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
GlobeNewswire - Mon Dec 23, 7:15AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has completed patient enrollment in a multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Integra Dermal Regeneration Template to the standard of care for the treatment of diabetic foot ulcers. Integra Dermal Regeneration Template is an advanced bilayer skin replacement system designed to provide immediate wound closure and permanent regeneration of the dermis.
Cooperative Investigations, Clinical Studies, Conference Calls, New Drug Applications, and Strategies- Research Report on Insys, Integra, Bio-Reference, Raptor, and Ironwood
PR Newswire - Tue Dec 17, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
IART Publishes Positive Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 16, 5:10PM CST
IART discloses encouraging results from the clinical study of NeuraGen Nerve Guide
Integra LifeSciences Announces NeuraGen(R) Clinical Study Published in Journal of Hand Surgery
GlobeNewswire - Thu Dec 12, 7:30AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the publication of the clinical study, Collagen Conduit Versus Microsurgical Neurorraphy: 2-Year Follow Up of a Prospective, Blinded Clinical and Electrophysiological Multicenter Randomized, Controlled Trial, in the December issue of The Journal of Hand Surgery.
U.S. Analytical Laboratory Instrument Manufacturing Industry Shipment to Reach US$21 Billion by 2017
M2 - Mon Dec 02, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/j79g3t/analytical) has announced the addition of Supplier Relations US, LLC's new report "Analytical Laboratory Instrument Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]" to their offering. The industry's revenue for the year 2012 was reported at $14.6 billion USD, with an estimated gross profit of 35.98%. Import was valued at $5.6 billion USD from 116 countries. The industry also exported $8.7 billion USD worth of merchandise to 205 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2012 was $11.5 billion USD. At 174 pages with over 150 charts and tables, the report covers topics such as current macroeconomic trends, granular product data, global trade, channel mix, government demand, and labor structure. It uses over a decade of historical data to forecast industry trends through 2017 on the domestic market, global market and overseas growth opportunities. This current report contains shipment data, inventory levels, international trade volume, and industry specific price indices available through September 2013. Industry analysts and Fortune 500 customers rely on this quarterly report to make accurate forecasts and planning in today's uncertain economy. In this report, you will find industry data on the following major categories: 2013-2017 5-Year Forecast Industry Income Statement Industry Balance Sheet Capital Expenditure Industry Cost Analysis Industry Pricing Analysis Industry Foreign Trade Industry Structure Competitive Landscape Companies Mentioned: - Affymetrix, Inc. - Agilent - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Bruker BioSciences Corporation - Coherent, Inc. - FEI Company - Hologic, Inc. - IDEXX Laboratories, Inc. - Integra LifeSciences Holdings Corporation - Life Technologies Corporation - Mettler-Toledo International Inc. - Millipore Corporation - PerkinElmer, Inc. - Siemens AG - Thermo Fisher Scientific - Thermo Fisher Scientific, Inc. - Thoratec Corporation - Veeco Instruments, Inc. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/j79g3t/analytical Source: Supplier Relations US, LLC About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Integra LifeSciences to Participate in the Piper Jaffray Healthcare and Oppenheimer Healthcare Conferences in December
GlobeNewswire - Mon Nov 18, 8:00AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month:
Integra LifeSciences to Participate in the Barclays Global Healthcare Conference in March
GlobeNewswire - Mon Mar 03, 3:15PM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conference next month:
Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges
GlobeNewswire - Thu Feb 27, 8:51AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the Integra Titanium Bone Wedges, designed for internal fixation for bone fractures or osteotomies in the foot and ankle. The system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), and will be featured at the American College of Foot and Ankle Surgeons (ACFAS) 72 Annual Scientific Conference, February 27 - March 2, 2014, in Orlando, Florida.
Integra LifeSciences Appoints Kenneth Burhop, Ph.D., as Corporate Vice President and Chief Scientific Officer
GlobeNewswire - Tue Feb 25, 7:00AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Kenneth Burhop has joined Integra as Corporate Vice President, Chief Scientific Officer. Dr. Burhop will be responsible for setting Integra's strategic scientific vision and roadmap, and will lead the Company's portfolio prioritization and management, and the scientific evaluation of corporate development and new product opportunities.
Integra LifeSciences Reports Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Feb 25, 5:00AM CST
Increases Fourth Quarter Revenues 3% to $221 Million
Integra LifeSciences to Participate in the 2014 Citi Global and RBC Capital Markets Healthcare Conferences in February
GlobeNewswire - Mon Feb 10, 8:00AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month:
Global Biomaterials Market 2012-2016: High R&D Costs Could Pose a Challenge to the Growth of the Market
M2 - Wed Feb 05, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/kl58bq/global) has announced the addition of the "Global Biomaterials Market 2012-2016" report to their offering. The analysts forecast the Global Biomaterials market to grow at a CAGR of 14.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biomaterials market has also been witnessing the emergence of innovative biomaterial products. However, high R&D costs could pose a challenge to the growth of this market. The key vendors dominating this space include Biomet Inc., Evonik Industries AG, Exactech Inc., and Wright Medical Group Inc. The other vendors mentioned in this report are 3DM Inc., AdvanSource Biomaterials Corp., Allergan Inc., Alphatec Spine Inc., Amedica Corp., Angiotech Pharmaceuticals Inc., Basf SE, Bayer AG, Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioSyntech Inc., Cam Bioceramics BV, Carpenter Technology Corp., Ceradyne Inc., Ceramtec Collagen Matrix Inc., CollPlant Holdings Ltd., Covalon Technologies Ltd., CryoLife Inc., Dentsply International Inc., Depuy Orthopaedics Inc., Dsm Biomedical Inc., ETEX Corp., Heraeus Medical Components Inc., Hycail Finland OY, Integra LifeSciences Holdings Corp., Invibio Ltd., Kyocera Corp., Landec Corp., Materion Corp., Medtronic Inc., Morgan Technical Ceramics, Orthovita Inc., Osteotech Inc., Purac Biomaterials, RTI Biologics Inc., Sigma-Aldrich Corp., Starch Medical Inc., Stryker Corp., Ticona GmbH, Ulbrich Stainless Steels & Special Metals Inc., and Zimmer Holdings Inc. Commenting on the report, an analyst from the team said: There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation. For more information visit http://www.researchandmarkets.com/research/kl58bq/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Use Options For A Chance To Buy IART At A 24% Discount
at The Street - Tue Feb 04, 11:29AM CST
Looking back to 90 days ago, Integra LifeSciences Holdings Corp priced a 3,500,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go...
Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien
GlobeNewswire - Wed Jan 15, 3:05PM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed the acquisition of DuraSeal product lines from Covidien. Now, together with our DuraGen(R) family of grafts, Integra offers surgeons the largest portfolio of dural repair solutions.
Integra LifeSciences to Host Its Fourth Quarter 2013 Earnings Results Conference Call on February 25, 2014
GlobeNewswire - Mon Jan 13, 8:03AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2013 financial results on Tuesday, February 25, 2014. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
Annual J.P. Morgan Healthcare Conference Presentations, Results of Self-Tender Offer, and Executive Appointment - Research Report on ICU Medical, Integra, Taro, AMAG, and Array BioPharma
PR Newswire - Fri Jan 10, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting ICU Medical, Inc. (NASDAQ: ICUI), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Taro Pharmaceutical Industries Ltd. (NYSE: TARO), AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), and Array BioPharma Inc. (NASDAQ: ARRY). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Integra Lifesciences Holdings Corp (IART) Enters Overbought Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 7:38AM CST
Integra Lifesciences Holdings Corp (IART) Enters Overbought Territory
Integra LifeSciences to Participate in the 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Mon Dec 30, 3:05PM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Mr. Peter Arduini, Integra's President and Chief Executive Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
GlobeNewswire - Mon Dec 23, 7:15AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has completed patient enrollment in a multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Integra Dermal Regeneration Template to the standard of care for the treatment of diabetic foot ulcers. Integra Dermal Regeneration Template is an advanced bilayer skin replacement system designed to provide immediate wound closure and permanent regeneration of the dermis.
Cooperative Investigations, Clinical Studies, Conference Calls, New Drug Applications, and Strategies- Research Report on Insys, Integra, Bio-Reference, Raptor, and Ironwood
PR Newswire - Tue Dec 17, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
IART Publishes Positive Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 16, 5:10PM CST
IART discloses encouraging results from the clinical study of NeuraGen Nerve Guide
Integra LifeSciences Announces NeuraGen(R) Clinical Study Published in Journal of Hand Surgery
GlobeNewswire - Thu Dec 12, 7:30AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the publication of the clinical study, Collagen Conduit Versus Microsurgical Neurorraphy: 2-Year Follow Up of a Prospective, Blinded Clinical and Electrophysiological Multicenter Randomized, Controlled Trial, in the December issue of The Journal of Hand Surgery.
U.S. Analytical Laboratory Instrument Manufacturing Industry Shipment to Reach US$21 Billion by 2017
M2 - Mon Dec 02, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/j79g3t/analytical) has announced the addition of Supplier Relations US, LLC's new report "Analytical Laboratory Instrument Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]" to their offering. The industry's revenue for the year 2012 was reported at $14.6 billion USD, with an estimated gross profit of 35.98%. Import was valued at $5.6 billion USD from 116 countries. The industry also exported $8.7 billion USD worth of merchandise to 205 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2012 was $11.5 billion USD. At 174 pages with over 150 charts and tables, the report covers topics such as current macroeconomic trends, granular product data, global trade, channel mix, government demand, and labor structure. It uses over a decade of historical data to forecast industry trends through 2017 on the domestic market, global market and overseas growth opportunities. This current report contains shipment data, inventory levels, international trade volume, and industry specific price indices available through September 2013. Industry analysts and Fortune 500 customers rely on this quarterly report to make accurate forecasts and planning in today's uncertain economy. In this report, you will find industry data on the following major categories: 2013-2017 5-Year Forecast Industry Income Statement Industry Balance Sheet Capital Expenditure Industry Cost Analysis Industry Pricing Analysis Industry Foreign Trade Industry Structure Competitive Landscape Companies Mentioned: - Affymetrix, Inc. - Agilent - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Bruker BioSciences Corporation - Coherent, Inc. - FEI Company - Hologic, Inc. - IDEXX Laboratories, Inc. - Integra LifeSciences Holdings Corporation - Life Technologies Corporation - Mettler-Toledo International Inc. - Millipore Corporation - PerkinElmer, Inc. - Siemens AG - Thermo Fisher Scientific - Thermo Fisher Scientific, Inc. - Thoratec Corporation - Veeco Instruments, Inc. - Waters Corporation For more information visit http://www.researchandmarkets.com/research/j79g3t/analytical Source: Supplier Relations US, LLC About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Integra LifeSciences to Participate in the Piper Jaffray Healthcare and Oppenheimer Healthcare Conferences in December
GlobeNewswire - Mon Nov 18, 8:00AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences next month:
